Over the past 2 decades, treatment options for multiple myeloma have increased ... “We’re all trained to wait to treat myeloma until there’s end-stage organ damage, but we have to challenge ...

A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone with multiple myeloma new, healthy bone marrow. It replaces the bone marrow harmed by myeloma ...

International Myeloma Foundation: “Multiple Myeloma and Anemia,” “Heart and Lung Complications.” Memorial Sloan Kettering Cancer Center: “Bone-Related Problems in Multiple Myeloma ...

Multiple myeloma (MM) is a malignant plasma cell disorder ... tumor biology but other factors such as tumor burden, extent of organ damage and performance status of the patient are important ...

Multiple myeloma is a rare type of cancer. It starts with the uncontrolled production of plasma cells. These are a type of white blood cell in the bone marrow. Healthy plasma cells make antibodies ...

Multiple myeloma: a blood cancer that develops in the plasma cells of the bone marrow ... “Even though in the real world a majority of patients are not as fit in terms of performance status, organ ...

The FDA has approved Bristol-Myers Squibb’s Abecma (idecabtagene vicleucel) for multiple myeloma, the first cell ... One patient developed fatal multi-organ damage and one patient with fatal ...

The ACCoRD trial, conducted across 79 UK hospitals, enrolled patients 18 years or older with relapsed multiple myeloma requiring treatment for first progressive disease at least 12 months after an ...